Archive for the ‘Diabetes’ Category

Team-Based Approach Improves Diabetes Care

Friday, February 8th, 2008

Due to the success of the first three years of the American College of Physicians (ACP) and the American College of Physicians Foundation (ACPF) Diabetes Initiative, the program has received additional funding from Novo Nordisk Inc. to continue the initiative for an additional two years through December 2009. "The results of ...

Deaths Stop Part Of Diabetes Trial

Thursday, February 7th, 2008

Part of a large North American clinical trial comparing aggressive with less aggressive blood sugar treatment of diabetes and cardiovascular disease in adults with type 2 diabetes has stopped 18 months early because the more aggressive treatment increased risk of death. The less aggressive treatment arm of the study has ...

The University Of Miami Is Enrolling Patients With Chronic Diabetic Foot Ulcers For MATRIX Clinical Trial

Monday, December 3rd, 2007

The University of Miami Department of Dermatology announced it is recruiting patients with lower extremity diabetic foot ulcers to participate in the MATRIX clinical trial. The MATRIX trial will study the effects of Excellarateâ„¢ (GAM501) (Ad5PDGF-B/bovine Type I collagen gel) for the potential treatment of patients with neuropathic non-healing diabetic ...

Clal Biotechnology Industries And Teva Pharmaceuticals Solidify Their Collaboration For Final Stage Development Of Type 1 Diabetes Drug

Monday, December 3rd, 2007

Clal Biotechnology Industries Ltd., (TASE: CBI), an investment group in the field of life sciences, announced recently that Andromeda Biotech Ltd., a wholly owned subsidiary of CBI, signed a Term Sheet with Teva to develop and commercialize DiaPep277, an innovative and advanced drug for the treatment of type 1 diabetes. ...

Animal Insulin Still Available, Says Wockhardt UK

Friday, November 30th, 2007

People with diabetes will still have access to animal insulin once Novo Nordisk withdraws its pork (porcine) insulins this December. Wockhardt UK says it will continue to supply Hypurin porcine and bovine insulin, giving people with diabetes a much-needed choice of treatment. Cathy Moulton, Diabetes UK care advisor , maintains that it ...

Dogs Sniff Out Diabetes

Friday, November 23rd, 2007

Queen's University researchers are appealing for volunteers to help investigate whether dogs can reliably detect changes in their owner's diabetic state. Dr Deborah Wells from the School of Psychology at Queen's and Dr Shaun Lawson from the University of Lincoln are appealing for 100 Type One diabetics to complete an online ...

CV Therapeutics’ Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c And Other Markers Of Diabetes In MERLIN TIMI-36

Wednesday, November 7th, 2007

CV Therapeutics, Inc. (Nasdaq: CVTX) announced that data from a prospectively identified analysis of 2,220 diabetic patients from the MERLIN TIMI-36 study showed that Ranexa(R) (ranolazine extended-release tablets) significantly reduced hemoglobin A1c (HbA1c), increased the number of patients achieving the clinical HbA1c treatment target of 7.0 percent or less and ...

Study Into Insulin-Boosting Medication And The Ability To Survive Heart Attack

Wednesday, November 7th, 2007

Mayo Clinic researchers helped clarify a growing concern about the link between diabetes mellitus treatments and heart attack with the first large, population-based study showing that a group of common medications does not reduce diabetic patients' heart attack survival rates. These results were presented at the American Heart Association's Scientific ...

Diabetes And Related Blindness On The Rise In Minnesota

Wednesday, November 7th, 2007

Both Type 1 and 2 diabetes are on the rise nationally, and in Minnesota, one in four either have diabetes or are at risk of developing it, compared to one in five in 2006. According to the Minnesota Department of Health, diabetes is the leading cause of blindness among Minnesotans ...